US EditionPopular weight loss drug may increase vision loss risk
Summary by Knowridge Science Report
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Popular weight loss drug may increase vision loss risk
A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a higher risk of developing a rare but serious eye condition that can cause permanent vision loss. This condition, called NAION (non-arteritic anterior ischemic optic neuropathy), occurs when blood flow to the optic […] The post Popular weight loss drug may increase vision loss risk appeared first on Knowridge Science Report.
VivaBem, UOL's new health and well-being channel with reliable and scientifically based information, tested tips, and expert guidance
·Brazil
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
